Mirae Asset Global Investments Co. Ltd. Boosts Position in The Cooper Companies, Inc. (NASDAQ:COO)

Mirae Asset Global Investments Co. Ltd. boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 15.1% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 26,189 shares of the medical device company’s stock after buying an additional 3,440 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Cooper Companies were worth $2,194,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of COO. Price T Rowe Associates Inc. MD raised its stake in shares of Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company’s stock valued at $324,466,000 after purchasing an additional 2,957,421 shares during the period. Norges Bank purchased a new stake in shares of Cooper Companies during the fourth quarter valued at approximately $217,906,000. FMR LLC raised its stake in shares of Cooper Companies by 97.6% during the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company’s stock valued at $203,911,000 after purchasing an additional 1,095,805 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Cooper Companies during the fourth quarter valued at approximately $64,826,000. Finally, Wealthfront Advisers LLC raised its stake in shares of Cooper Companies by 4,594.1% during the fourth quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company’s stock valued at $52,383,000 after purchasing an additional 557,673 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

COO has been the topic of a number of analyst reports. Robert W. Baird dropped their price objective on shares of Cooper Companies from $107.00 to $97.00 and set an “outperform” rating on the stock in a research note on Friday, May 30th. Wells Fargo & Company dropped their price objective on shares of Cooper Companies from $118.00 to $93.00 and set an “overweight” rating on the stock in a research note on Friday, May 30th. BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $76.00 price objective (down previously from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Finally, Needham & Company LLC raised shares of Cooper Companies from a “hold” rating to a “buy” rating and set a $94.00 price target for the company in a research report on Tuesday, June 17th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $99.70.

Cooper Companies Stock Down 0.0%

COO stock opened at $73.01 on Friday. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $14.60 billion, a P/E ratio of 35.44, a PEG ratio of 1.78 and a beta of 0.99. The firm has a 50 day simple moving average of $75.78 and a 200-day simple moving average of $83.48.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. During the same period in the previous year, the business earned $0.85 EPS. The business’s quarterly revenue was up 6.3% on a year-over-year basis. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.